title: [USE OF HYALURONIC ACID ALONE AND COMBINED WITH ARGENTIC SULPHADIAZINE IN REACTIVE PERFORATING COLLAGENOSIS. A CASE REPORT].
abstract: The dermatosis known since reactive perforating collagenosis (RPC) is an injury that is characterized by the transepidermal elimination of the collagen. Two forms of presentation exist: the inherited one and the acquired one. The acquired form appears in the adult age, principally in diabetics with renal chronic insufficiency. The hyaluronic acid is a glycosaminoglycan of high place molecular weight that is synthesized in the system vacuolar of the fibroblasts and other cells, since they are the keratinocytes, with help of the factors of growth and in other cytokines. The argentic sulphadiazine is a hackneyed medicament of antiinfectious action that is in use for anticipating and treating the infections in wounds and burns of degree the II and IIIrd. His action realizes it on bacteria and fungi.
authors.forename: Miguel Mauricio
authors.initials: MM
authors.lastname: Cano Cerro
authors.forename: Eva María
authors.initials: EM
authors.lastname: Jiménez Fornés
authors.forename: María José
authors.initials: MJ
authors.lastname: Fabrich Lloret
authors.forename: Ovidio
authors.initials: O
authors.lastname: Gans Cuenca
authors.forename: Mara
authors.initials: M
authors.lastname: Redón Martínez
authors.forename: Elena
authors.initials: E
authors.lastname: Sales Molió
mesh_terms: D003095:Collagen Diseases / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D006801:Humans; D006820:Hyaluronic Acid / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D012837:Silver Sulfadiazine / Q000627:therapeutic use*; D012873:Skin Diseases, Genetic / Q000188:drug therapy*
chemical_list: D006820:Hyaluronic Acid; D012837:Silver Sulfadiazine